SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
HAEMONETICS CORP
@HAE_InsiderForm 4 Filing: Johnson Lloyd Emerson Acquires (Grant) shares of $HAE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
HAEMONETICS CORP
Ticker: $HAE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-24
Shares: 2,538
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Johnson Lloyd Emerson, holds the title of Director at HAEMONETICS CORP.
On 2026-07-24, the insider transacted 2,538 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Johnson Lloyd Emerson (Director) was granted $0 of $HAE
Post-Transaction Position: 15,471 shares
SEC Accession No: 0000313143-26-000105 (CIK: 1708823)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.